# Adnavance Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adnavance-technologies

- Industry: Biotechnology
- Headquarters: Vancouver, Canada
- Total disclosed funding: $7.5M
- Latest round: Series B (Feb 26, 2008)
- Investors on record: 4

## About

Adnavance Technologies is Canada-based company that operates as a provider of direct detection molecular diagnostic tests for medical applications.

## Funding rounds

- Series B, Feb 26, 2008, $3.6M — BDC Capital, GrowthWorks Capital, JovInvestment Management
- Series A, Nov 29, 2005, $3.9M — BDC Capital, GrowthWorks Capital, Canadian Medical Discoveries Fund Inc.

## Investors

- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series A, Series B
- GrowthWorks Capital (https://capitalatlas.ai/funds/growthworks-capital) — Series A, Series B
- Canadian Medical Discoveries Fund Inc. — Series A
- JovInvestment Management — Series B